Development of a biocompatible polymeric chitosan system for the release of compounds with leishmanicidal activity
Leishmaniasis is a tropical disease caused by parasites of the genus Leishmania spp; it presents different clinical manifestations, of which cutaneous leishmaniasis is the most common form, and it is endemic in more than 70 countries worldwide. Only four drugs are registered for the treatment of the...
Saved in:
Main Authors: | Jorge Higuita-Castro, Iván D. Vélez, Diana M. Escobar, Javier Murillo, Tatiana Pineda, Victoria Ospina, Sara M. Robledo |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e3207489cef647789f04466d3db7679c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy of amphotericin B-loaded chitosan nanoparticles and free amphotericin B drug against Leishmania tropica
by: Aamir Sohail, et al.
Published: (2021) -
SYNTHESIS AND IN VITRO LEISHMANICIDAL AND CYTOTOXIC ACTIVITIES OF 2-STYRYLQUINOLINES ANALOGS
by: Ana M. MESA, et al.
Published: (2009) -
Chitosan And N, N, N-Trimethyl Chitosan Nanoparticle Encapsulation Of Ocimum Gratissimum Essential Oil: Optimised Synthesis, In Vitro Release And Bioactivity
by: Onyebuchi C, et al.
Published: (2019) -
Leishmaniasis Recidivans in Rural Venezuela
by: Ariadna Perez Sanchez, et al.
Published: (2020) -
Chiclero's ulcer: An unusual presentation of Leishmania tropica in Syria
by: Alexey Youssef, et al.
Published: (2018)